Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Paulig adds nature to its sustainability ambitions to strengthen protecting biodiversity

International food and beverage company Paulig has updated its sustainability focus areas and added Nature as part of its ambitious Sustainability Approach 2030. In addition to reducing the climate impact of its operations and value chain, Paulig wants to take stronger actions to protect biodiversity. Paulig has already started collaborating with its partners and suppliers to prevent and minimise biodiversity loss in its value chain. The next step is to set science-based targets for nature actions. “As an international food and beverage company, we are dependent on nature. Without

Saab Receives Order for Gripen Development and Operational Support

Saab has received an order from the Swedish Defence Materiel Administration (FMV) for the maintenance and provision of resources for development and operational support of Gripen. The total value of the order is SEK 345 million.The order from FMV mainly comprises operations relating to rigs, simulators, and test aircraft for verification and validation of the Gripen fighter aircraft system, versions C/D and E, as well as operational support for Gripen C/D. “We look forward to continuing to support our customers by delivering the support they need to optimally conduct their operations,”

Cessatech - Ventis Pharma US partnership - Q&A

On 30 June – Cessatech A/S (“Cessatech” or “the Company”) releases a short Question and Answers (Q&A) overview, based all the positive feedback and questions from the exclusive US license and collaboration agreement with Ventis Pharma.Selected top 10 investor questions 1. What is the expected revenue for 2024? A: Revenue guidance will be provided once we have seen the early progression of the launch – but we expect a significant amount 2. Could you explain the $200-400M market opportunity?   A: Ventis Pharma expects this ‘combined’ opportunity to be both the ‘early access

#23-59 Trading halt in Meltron AB

NGM has decided to halt the trading in the shares of Meltron AB effective immediately. Trading will be halted until further notice in accordance with Chapter 11, Section 12 of the Securities Market Act. The trade halt is due to non-disclosure of inside information about the issuer or the issuer’s financial instrument pursuant Chapter 22, Section 1, Paragraph 3 of the Securities Market Act. The Financial Supervisory Authority has been notified about the trade halt and has decided that it will remain until further notice in accordance with Chapter 22, Section 1 of the Securities Market Act.

Comment from the Independent Bid Committee of IRRAS regarding the public offer from IR Holding Bidco

On 30 June 2023, Legacy Capital, Spetses, Bacara, Lexington, Kleanthis G. Xanthopoulos, Panormos, Philippe Audi, and Nicolas Murat (the “Bid Consortium”), through IR Holding Bidco Inc. (the “Offeror”), announced a public offer of SEK 0.18 in cash per share to the shareholders of IRRAS AB (publ) (”IRRAS”) (the “Offer”). Marios Fotiadis, chairman of the board of IRRAS, and Kleanthis G. Xanthopoulos, board member and former CEO of IRRAS, are shareholders of IRRAS and are participating in the Offer as part of the Bid Consortium. They will contribute their shares in IRRAS to the Offeror upon

IR Holding Bidco Inc. announces a public cash offer to the shareholders of IRRAS AB

THIS PRESS RELEASE IS NOT AN OFFER, WHETHER DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION WHERE SUCH OFFER PURSUANT TO LEGISLATION AND REGULATIONS IN SUCH RELEVANT JURISDICTION WOULD BE PROHIBITED. SHAREHOLDERS NOT RESIDENT IN SWEDEN WHO WISH TO ACCEPT THE OFFER (AS DEFINED BELOW) MUST MAKE INQUIRIES CONCERNING APPLICABLE LEGISLATION AND POSSIBLE TAX CONSEQUENCES. SHAREHOLDERS SHOULD REFER TO THE OFFER RESTRICTIONS INCLUDED IN THE SECTION TITLED “IMPORTANT INFORMATION” AT THE END OF THIS PRESS RELEASE AND IN THE

More than 200 Norwegian suppliers involved in Yggdrasil and Valhall PWP-Fenris

So far, more than 200 Norwegian supplier companies are directly contributing to the two upcoming major developments on the Norwegian shelf – Yggdrasil and Valhall PWP-Fenris. And the number will grow in the years to come.  “The Yggdrasil and Valhall PWP-Fenris development projects are direct responses to the activity package approved by the Storting three years ago. It aimed to secure activity, protect jobs, develop expertise and further develop the industry at a time characterised by the pandemic, record-low oil prices and steep declines in investments. Together with our

TF Bank AB (publ): Invitation to the presentation of the Interim report for January – June 2023

TF Bank AB will publish its interim report for the period January – June 2023 on Thursday 13 July 2023 at 07.00 CET. We welcome media, institutional investors, analysts and other interested parties to participate in a conference call at 08.15 CET. Agenda (CET) 07.00 – Interim report published 08.15 – Conference call with CEO Joakim Jansson and CFO Mikael Meomuttel who will present the Interim report. It will be possible to ask questions after the presentation. To follow the conference call online go to www.tfbankgroup.com or click on the link below. The presentation will be

OrganoClick’s brand OrganoTex executes on growth strategy and expands to several new geographical markets

The demand and interest of the eco-labelled and PFAS-free OrganoTex textile and shoe waterproofing products continues to be strong. OrganoClick has therefore pursued an ambitious expansion plan to broaden the geographic reach and cater to a wider customer base, establish a strong presence and capitalize on emerging opportunities. The company has now partnered with carefully selected distributors and agents to penetrate new regions and unlock new business opportunities. During Q3 2023, OrganoTex will be launched in the following new markets: Germany, Austria, Italy, Poland,

Number of shares and votes in EQT

The number of shares and votes in EQT AB (publ) (“EQT”) has changed as a result of a cancellation of 7,068,423 class C shares held by EQT. The cancellation was resolved by the Annual Shareholders’ Meeting 2023.The total number of shares has decreased by 7,068,423 shares, from 1,193,692,014 shares to 1,186,623,591 shares, while the number of votes has decreased by 706,842.30, from 1,186,223,738.40 to 1,185,516,896.10. The remaining shares are divided into 1,185,393,930 ordinary shares and 1,229,661 class C shares. No shares are held by EQT after the cancellation. As a result of the

Peab builds logistics facilities in Helsingborg

Peab has been commissioned to build three logistics facilities in Helsingborg. The customer is Catena and the contract is worth SEK 700 million.The new logistics facilities will be located in the Långeberga area in Helsingborg. The buildings will contain logistics space and adjacent offices for a total of GFA 75,000 m2 and be built according to BREEAM Excellent. “We’re proud to have been entrusted with taking on this extensive construction project that contributes to the continued development of the Långeberga area. The project’s ambition is to be at the forefront of future logistics

Raute Corporation postpones the publication of its half-year report for 2023 – the new publication date is 25 August 2023

Raute Corporation, Stock Exchange Release, 30 June 2023 at 9:30 EESTRaute Corporation postpones the publication of its half-year report for 2023 – the new publication date is 25 August 2023Raute Corporation postpones the publication of its half-year report for 2023 from the previously announced date of 27 July 2023. The new publication date is Friday 25 August 2023, and the report will be published at approximately 8:30 o’clock.   The postponement is due to the ongoing implementation of the renewed ERP-system at Raute Corporation’s main unit in Nastola during the second quarter of

BioStock: Invent Medic expands product portfolio with period panties

With the acquisition of FlowCup, Invent Medic took a clear position in the women’s health market. Now, the company is strengthening that position with the launch of the period panty Flow Undies. BioStock contacted Diana Lidforsen to find out more about what this means for the company.Read the full article at biostock.se: https://www.biostock.se/en/2023/06/invent-medic-expands-product-portfolio-with-period-panties/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Tobii Dynavox enters agreement to acquire Rehadapt Engineering, improving mounting solutions for communication aids

Tobii Dynavox AB (“Tobii Dynavox”), the world leader in assistive communication, has entered into an agreement to acquire all the shares in the German companies EIYott GmbH and Rehadapt Engineering GmbH & Co. KG (together “Rehadapt”). Rehadapt is a worldwide provider of mounting solutions for assistive technology. Tobii Dynavox will pay EUR 15 million in cash, on a cash and debt free basis. The transaction is subject to relevant regulatory approvals and other customary conditions, which are expected to be completed in the third quarter of 2023.  Background Rehadapt is a premium

Invitation to presentation of Balco Group’s second quarter report 2023

Växjö, June 30, 2023Balco Group’s interim report for the second quarter 2023 will be published at 13:00 CET on July 14, 2023. A webcast conference call will be held at 14:00 CET on the same day, where CEO and President Camilla Ekdahl and CFO Michael Grindborn will present the results for the second quarter of 2023. The presentation material will be available before the start of the conference call on the Balco Group website www.balcogroup.se. During the webcast there will be an opportunity to ask questions and follow the presentation material. It will also be possible to view the

Invitation to conference call with web presentation of Cloetta AB´s interim report Q2 2023

Cloetta AB will publish the interim report for the period 1 April – 30 June 2023 on Friday 14 July 2023 at 7.30 a.m. CEST. Following this report Cloetta will organize a conference call with web presentation for media and the financial community.President and CEO Henri de Sauvage Nolting and CFO Frans Rydén will present and comment on the report. After the presentation there will be time for questions, both on the phone and in the web presentation. Time for the publication of the interim reportFriday 14 July at 07:30 a.m. CEST  Time for conference call and web presentationFriday 14

Increased number of shares and voting rights in Catena Media plc

Catena Media plc announces that the number of shares and voting rights in the company has increased by 70,550 due to the exercise of Catena Media’s warrants (CTM TO1) during the 13th warrant exercise period that followed publication of the Interim report for the first quarter of 2023. As announced on 29 May 2023, 70,550 warrants were used to subscribe for the same number of new ordinary shares in Catena Media during the 13th warrant exercise period. The new shares were then registered with the Maltese authorities. As of 30 June 2023, the last trading day of the month, the number of

Change in number of shares and votes in Boliden

The Annual General Meeting in Boliden on April 25, 2023 resolved on an automatic share redemption procedure including a share split 2:1 of Boliden’s shares, whereby one existing share was divided into two shares. As previously communicated, the number of shares and votes in Boliden therefore increased during May 2023 by 273,511,169 to 547,022,338.  The 273,511,169 redemption shares issued through the share split were redeemed during June 2023 as part of the redemption procedure. As of June 30, 2023, the number of shares and votes in Boliden therefore again totals 273,511,169.

New number of shares and votes in Moberg Pharma AB (publ)

STOCKHOLM, June 30[th], 2023, Moberg Pharma AB (publ) announced that the total number of common shares in the company has increased to 10,272,933. The 187,000 newly issued shares are held by the company to secure its commitments under incentive programmes.As per June 30[th], 2023, the total number of shares in Moberg Pharma AB (publ) amounts to 10,272,933. All shares are common shares. The total number of votes are 10,272,933. The increase in the number of shares and votes results from an issue of 187,000 class C shares. The newly issued class C shares have been repurchased and, by virtue

Invitation to presentation of Orkla’s second quarter 2023 results, Friday 14 July

Orkla will report its first quarter 2023 results on Friday, 14 July 2023 at 7:00 a.m. CEST.The quarterly report and the presentation material will be available at this time at: https://investors.orkla.com.The quarterly results will be presented at 8:00 a.m. CEST at the Orkla House, Drammensveien 149, Oslo. The presentation and subsequent Q&A session will be held in English and may be viewed in a live webcast at https://investors.orkla.com (direct link: https://events.webcast.no/orkla-asa-1/presentations/QkHyiBdm3SU53TWn0GVO) or followed by telephone (listen only): Dial-in details:

Proact hybrid cloud service achieves VMware Cloud Verified status

Proact, Europe's leading independent data centre and cloud services provider, today announced that it has achieved VMware Cloud Verified status for Proact Hybrid Cloud (PHC).The Cloud Verified badge signals to customers that they are partnering with a provider validated by VMware to deliver cloud infrastructure as a service. The badge assures that Proact offer its own services on top of the complete VMware validated Cloud infrastructure. When engaging with a Cloud Verified partner, like Proact, customers have access to the full set of VMware Cloud infrastructure capabilities including

Invitation to presentation of Scandic’s interim report for the second quarter 2023

Scandic Hotels Group will present its interim report for the second quarter 2023 in a webcast at 09.00 CEST on July 14, 2023. The report will be published at 07.30 CEST on the same day.Scandic’s President & CEO Jens Mathiesen will present the report together with CFO Åsa Wirén in a webcast and telephone conference. The presentation is in English. Time: Friday, July 14, 2023, at 09.00 CEST. Location: Webcast and telephone conference. Telephone numbers: Dial-in number to the telephone conference will be received by registering on the link below. After the registration you will be

Increased number of shares and votes in Karnov Group AB (publ)

As of today, 30 June 2023, the total number of shares and votes in Karnov Group AB (publ) amounts to 108,102,047 shares and 107,898,735.2 votes.During the month of June 2023, a total of 29,474 shares of series C, previously issued and repurchased under Karnov Group’s long-term incentive plan LTIP 2020, resolved by the annual general meeting in May 2020, were converted into ordinary shares. The number of ordinary shares has thus increased by 29,474 shares and the number of Class C shares has decreased by the same number of shares. The number of votes has increased by 26,526.6.   The

There are no items matching the current filter
There are no more items matching the current filter
Back to top